S.525 - Pharmaceutical Market Access and Drug Safety Act of 2009 Sponsor: Byron Dorgan / 111th Congress

Title
111th Congress - A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes. hidemore...
Summary
A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes. (by CRS)
Status
The bill has been introduced.

Customize

Customize the interests supporting and opposing this bill

To remove an interest, click the Remove button next to its name below this box.

To add an interest, choose one from this list:

To add an interest, click Support or Oppose.

You can share your customized pages with other people by sending them the URL for pages about this bill. Other MAPLight.org users will not see your customizations unless they use the URL you send them. To save your customizations for your next visit, create a free New Account, then Sign In.

Done

Interests who did want this bill to become law included these interests and specific groups:

Interests who did not want this bill to become law included these interests and specific groups:

Contribution data provided by the Center for Responsive Politics (OpenSecrets.org)

Comments RSS feed

Weighing Pros and Cons by Alina Fortson, Apr 23, 2009 (11:10pm)

The debate over importing pharmaceuticals into the United States has gone on for several years. Both sides make good points. One camp champions the idea that Americans deserve access to fairly priced (via competition) drugs. This seems reasonable until challenged with the claim that our market cannot guarantee a reduce in prices—perhaps the middle man will save money and the consumer will still lose—and this is not worth the cost of counterfeits threatening safety and a possible halt to drug research.

Reply to this comment
Reply to this comment close
[ Tags ]
[ Tags ] close
[ Spam ]
[ Spam ] close